Repligen Corp (RGEN)
162.28
-3.22
(-1.95%)
USD |
NASDAQ |
May 09, 12:54
Repligen Revenue (TTM): 607.45M for March 31, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 607.45M |
| December 31, 2023 | 638.76M |
| September 30, 2023 | 669.78M |
| June 30, 2023 | 729.33M |
| March 31, 2023 | 777.80M |
| December 31, 2022 | 801.54M |
| September 30, 2022 | 801.30M |
| June 30, 2022 | 778.77M |
| March 31, 2022 | 734.10M |
| December 31, 2021 | 670.53M |
| September 30, 2021 | 592.66M |
| June 30, 2021 | 508.50M |
| March 31, 2021 | 433.01M |
| December 31, 2020 | 366.26M |
| September 30, 2020 | 327.09M |
| June 30, 2020 | 302.47M |
| March 31, 2020 | 285.70M |
| December 31, 2019 | 270.24M |
| September 30, 2019 | 252.71M |
| June 30, 2019 | 232.80M |
| March 31, 2019 | 209.84M |
| December 31, 2018 | 194.03M |
| September 30, 2018 | 183.70M |
| June 30, 2018 | 170.75M |
| March 31, 2018 | 155.48M |
| Date | Value |
|---|---|
| December 31, 2017 | 141.24M |
| September 30, 2017 | 125.22M |
| June 30, 2017 | 113.32M |
| March 31, 2017 | 110.04M |
| December 31, 2016 | 104.54M |
| September 30, 2016 | 100.39M |
| June 30, 2016 | 95.53M |
| March 31, 2016 | 87.81M |
| December 31, 2015 | 83.54M |
| September 30, 2015 | 78.48M |
| June 30, 2015 | 73.94M |
| March 31, 2015 | 68.04M |
| December 31, 2014 | 63.55M |
| September 30, 2014 | 62.54M |
| June 30, 2014 | 66.08M |
| March 31, 2014 | 68.04M |
| December 31, 2013 | 68.17M |
| September 30, 2013 | 71.60M |
| June 30, 2013 | 67.88M |
| March 31, 2013 | 65.90M |
| December 31, 2012 | 62.27M |
| September 30, 2012 | 52.08M |
| June 30, 2012 | 44.63M |
| March 31, 2012 | 35.02M |
| September 30, 2011 | 29.26M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
232.80M
Minimum
Jun 2019
801.54M
Maximum
Dec 2022
539.04M
Average
600.06M
Median
Revenue (TTM) Benchmarks
| Perspective Therapeutics Inc | 0.00 |
| Retractable Technologies Inc | 43.60M |
| Xtant Medical Holdings Inc | 91.30M |
| Asensus Surgical Inc | 8.577M |
| Catheter Precision Inc | 0.442M |